Log In
Print this Print this

Regtect, acamprosate (NS-11)

  Manage Alerts
Collapse Summary General Information
Company Merck KGaA
Description3-Acetamido-1-propanesulfonic acid
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAddiction
Indication DetailsTreat alcohol dependence
Regulatory Designation
PartnerNippon Shinyaku Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today